Stockscreener 앱 받기
34.96
2.58%
0.88
시간 외 거래:
35.32
0.36
+1.03%
전일 마감가:
$34.08
열려 있는:
$34.01
하루 거래량:
627.43K
Relative Volume:
0.72
시가총액:
$3.88B
수익:
$418.33M
순이익/손실:
$-252.07M
주가수익비율:
-14.57
EPS:
-2.4
순현금흐름:
$-238.84M
1주 성능:
-5.05%
1개월 성능:
+0.06%
6개월 성능:
+26.99%
1년 성능:
+102.67%
1일 변동 폭
$33.96
$35.04
1주일 범위
$33.17
$39.64
52주 변동 폭
$16.01
$44.34
Zai Lab Limited Adr Stock (ZLAB) Company Profile
명칭
Zai Lab Limited Adr
전화
862161632588
주소
4560 JINKE ROAD, SHANGHAI
ZLAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
34.96 | 4.27B | 418.33M | -252.07M | -238.84M | -2.40 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-03-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-14 | 개시 | Morgan Stanley | Overweight |
| 2023-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 개시 | Macquarie | Outperform |
| 2021-10-12 | 개시 | Bernstein | Mkt Perform |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-04-15 | 개시 | Guggenheim | Buy |
| 2019-07-12 | 개시 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
| 2019-01-29 | 개시 | Credit Suisse | Outperform |
| 2018-11-21 | 개시 | Jefferies | Buy |
| 2018-06-21 | 재개 | Leerink Partners | Outperform |
| 2018-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 개시 | JP Morgan | Neutral |
| 2017-10-16 | 개시 | Leerink Partners | Outperform |
모두보기
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Is Zai Lab’s (ZLAB) Improving Efficiency Hinting at a Turning Point for Its Growth Strategy? - simplywall.st
Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings - MSN
8,230 Shares in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Purchased by Bank of New York Mellon Corp - Defense World
Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook - Yahoo Finance
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Sees Significant Increase in Short Interest - Defense World
What to expect from Zai Lab Limited Depositary Receipt in the next 30 daysHigh Return Strategy with Low Risk - Newser
Zai Lab (ZLAB) Projected to Post Quarterly Earnings on Thursday - Defense World
Zai Lab Announces Participation in Investor Conferences in June 2025 - FinancialContent
Brokerages Set Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) PT at $54.28 - Defense World
Happy City Holdings Limited’s (NASDAQ:HCHL) Quiet Period Set To End on August 4th - Defense World
Cerity Partners LLC Makes New $420,000 Investment in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World
Franklin FTSE Japan ETF (NYSEARCA:FLJP) Position Cut by Cerity Partners LLC - Defense World
Cerity Partners LLC Takes Position in KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ) - Defense World
Cerity Partners LLC Purchases Shares of 19,622 Gold Fields Limited (NYSE:GFI) - Defense World
Envestnet Asset Management Inc. Raises Stock Position in First Trust Intermediate Government Opportunities ETF (NYSEARCA:MGOV) - Defense World
Bank of New York Mellon Corp Buys 146,092 Shares of Schwab Short-Term U.S. Treasury ETF (NYSEARCA:SCHO) - Defense World
Zai Lab Limited's (NASDAQ:ZLAB) large institutional owners must be happy as stock continues to impress, up 4.9% over the past week - simplywall.st
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Shares Acquired by Envestnet Asset Management Inc. - Defense World
Knorr-Bremse (KNRRY) Expected to Announce Quarterly Earnings on Thursday - Defense World
Ero Copper (ERO) Expected to Announce Quarterly Earnings on Thursday - Defense World
Standard Chartered (SCBFY) Projected to Post Earnings on Thursday - Defense World
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Benzinga
Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities16.07.25News - Ariva
M&T Bank Corp Reduces Stock Holdings in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World
Zai Lab Limited - TradingView
Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 - Business Wire
Leerink Partnrs Issues Positive Outlook for Zai Lab Earnings - Defense World
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer - Business Wire
Cantor Fitzgerald Expects Reduced Earnings for Zai Lab - Defense World
Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo Finance
Metric Deep Dive: Understanding Winnebago Industries, Inc (WGO) Through its Ratios - DWinneX
Zai Lab Limited ADR (ZLAB) Stock: A Year of Stock Market Dynamics - investchronicle.com
10 Biotech Stocks Screaming a Buy - Insider Monkey
Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 - Business Wire
Zai Lab Limited ADR (ZLAB) Stock: Uncovering 52-Week Market Trends - investchronicle.com
CarParts.com Inc (PRTS) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize
Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Two Sigma Investments LP Trims Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Two Sigma Advisers LP Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Bank of America Corp DE Has $1.63 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus
Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - MSN
Zai Lab ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting - Business Wire
Zai Lab Limited (NASDAQ:ZLAB) Sees Large Drop in Short Interest - Defense World
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Yahoo Finance
What Analysts Were Expecting After Zai Lab Limited ADR (NASDAQ: ZLAB) fell -3.74% - Stocksregister
Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan
Northern Trust Corp Increases Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Limited Adr (ZLAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):